Clinical Trials
7
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)
- Conditions
- Primary Open-Angle Glaucoma (POAG)
- Interventions
- Other: Placebo
- First Posted Date
- 2025-03-30
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 102
- Registration Number
- NCT06903156
- Locations
- 🇷🇺
Kirov Regional State Budgetary Healthcare Institution "Kirov Clinical Ophthalmological Hospital", Kirov, Russian Federation
🇷🇺Federal State Budgetary Educational Institution of Higher Education "Moscow State Medical and Dental Institute named after A.I. Evdokimov" of the Ministry of Health of the RF, Moscow, Russian Federation
🇷🇺Federal State Autonomous Institution "Intersectoral Scientific and Technical Complex "Eye Microsurgery" named after Academician S.N. Fedorov" of the Ministry of Health of the RF, Moscow, Russian Federation
Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)Anxiety Disorders and Symptoms
- Interventions
- First Posted Date
- 2025-03-03
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 333
- Registration Number
- NCT06854601
- Locations
- 🇷🇺
State Autonomous Healthcare Institution of the Sverdlovsk Region "Multispecialty Clinical Medical Center 'Bonum', Yekaterinburg, Ural region, Russian Federation
🇷🇺Federal State Budgetary Educational Institution of Higher Education "Kazan State Medical University" Ministry of Health of the Russian Federation, Kazan, Russian Federation
🇷🇺State Budgetary Healthcare Institution "Specialized Clinical Psychiatric Hospital №1" of the Ministry of Health of the Krasnodar Territory, Krasnodar, Russian Federation
Safety and Efficacy of Sequential Treatment with Mexidol® in Patients with Chronic Cerebral Ischemia
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 318
- Registration Number
- NCT06834490
- Locations
- 🇷🇺
Municipal Autonomous Healthcare Insitution of the Order of the Red Banner of Labour "City Clinical Hospital No.1", Chelyabinsk, Russian Federation
🇷🇺State Budget Healthcare Institution of the Sverdlovsk Region "Sverdlovsk Regional Clinical Hospital No.1", Ekaterinburg, Russian Federation
🇷🇺Regional Budget Healthcare Institution "Ivanovo Regional Clinical Hospital", Ivanovo, Russian Federation
The Study of Efficacy and Safety of Mexidol® in Stroke Therapy (MIR)
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 304
- Registration Number
- NCT06437626
- Locations
- 🇰🇿
Almaty City Hospital № 7, Almaty, Kazakhstan
🇷🇺Tatarstan Republican Clinical Hospital, Kazan, Russian Federation
🇷🇺Interregional Clinical Diagnostic Center, Kazan, Russian Federation
MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG)
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 80
- Registration Number
- NCT06437639
- Locations
- 🇷🇺
Tyumen Scientific Center of the Russian Academy of Sciences, Tyumen, Russian Federation
- Prev
- 1
- 2
- Next